Maija E Miettinen1, Melissa C Smart2, Leena Kinnunen3, Christopher Mathews2, Valma Harjutsalo3,4,5,6, Heljä-Marja Surcel7, Christel Lamberg-Allardt8, Jaakko Tuomilehto3,9,10,11, Graham A Hitman2. 1. National Institute for Health and Welfare, Chronic Disease Prevention Unit, PO Box 30, 00271, Helsinki, Finland. maija.miettinen@thl.fi. 2. Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. 3. National Institute for Health and Welfare, Chronic Disease Prevention Unit, PO Box 30, 00271, Helsinki, Finland. 4. Folkhälsan Institute of Genetics, Folkhälsan Research Center, University of Helsinki, Helsinki, Finland. 5. Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 6. Research Program Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. 7. Impact Assessment Unit, National Institute for Health and Welfare, Oulu, Finland. 8. Department of Food and Environmental Sciences, University of Helsinki, Helsinki, Finland. 9. Center for Vascular Prevention, Danube-University Krems, Krems, Austria. 10. South Ostrobothnia Central Hospital, Seinäjoki, Finland. 11. Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract
AIMS/HYPOTHESIS: We investigated whether single nucleotide polymorphisms (SNPs) associated with 25-hydroxyvitamin D concentration in the metabolic pathway of vitamin D show different genotype distributions between Finnish families with an offspring with type 1 diabetes (cases) and families with a healthy offspring (controls). METHODS: A total of 31 SNPs in eight genes were studied in case and control mothers and family members (offspring with type 1 diabetes and healthy siblings, healthy control children and fathers) (n = 2,854). The 25-hydroxyvitamin D concentration was studied in 474 case and 348 matched control mothers during pregnancy. RESULTS: The genotype distributions of 13 SNPs (in the following genes: 7-dehydrocholesterol reductase NADSYN1/DHCR7, vitamin D receptor VDR, group-specific component GC and CYP27A1) that showed a nominal association with 25-hydroxyvitamin D concentration (p < 0.05) were compared between case and control families. SNPs in VDR had different genotype distributions between the case and control mothers (rs1544410, p = 0.007; rs731236, p = 0.003; rs4516035, p = 0.015), two SNPs (rs1544410 and rs731236) remaining significant after correction for multiple testing using a false discovery rate. The mean 25-hydroxyvitamin D concentrations during pregnancy did not differ between the case and control mothers. CONCLUSIONS/ INTERPRETATION: Our preliminary results suggest that the maternal genotypes of SNPs in VDR may influence the in utero environment and thus contribute to the early programming of type 1 diabetes in the fetus. It is possible that the effects are only relevant in the presence of vitamin D insufficiency.
AIMS/HYPOTHESIS: We investigated whether single nucleotide polymorphisms (SNPs) associated with 25-hydroxyvitamin D concentration in the metabolic pathway of vitamin D show different genotype distributions between Finnish families with an offspring with type 1 diabetes (cases) and families with a healthy offspring (controls). METHODS: A total of 31 SNPs in eight genes were studied in case and control mothers and family members (offspring with type 1 diabetes and healthy siblings, healthy control children and fathers) (n = 2,854). The 25-hydroxyvitamin D concentration was studied in 474 case and 348 matched control mothers during pregnancy. RESULTS: The genotype distributions of 13 SNPs (in the following genes: 7-dehydrocholesterol reductase NADSYN1/DHCR7, vitamin D receptorVDR, group-specific component GC and CYP27A1) that showed a nominal association with 25-hydroxyvitamin D concentration (p < 0.05) were compared between case and control families. SNPs in VDR had different genotype distributions between the case and control mothers (rs1544410, p = 0.007; rs731236, p = 0.003; rs4516035, p = 0.015), two SNPs (rs1544410 and rs731236) remaining significant after correction for multiple testing using a false discovery rate. The mean 25-hydroxyvitamin D concentrations during pregnancy did not differ between the case and control mothers. CONCLUSIONS/ INTERPRETATION: Our preliminary results suggest that the maternal genotypes of SNPs in VDR may influence the in utero environment and thus contribute to the early programming of type 1 diabetes in the fetus. It is possible that the effects are only relevant in the presence of vitamin Dinsufficiency.
Entities:
Keywords:
25-Hydroxyvitamin D; In utero; Maternal genotype; Pregnancy; Type 1 diabetes; VDR; Vitamin D
Authors: J Richard Pilsner; Howard Hu; Robert O Wright; Katarzyna Kordas; Adrienne S Ettinger; Brisa N Sánchez; David Cantonwine; Alicia L Lazarus; Alejandra Cantoral; Lourdes Schnaas; Martha Maria Téllez-Rojo; Mauricio Hernández-Avila Journal: Am J Clin Nutr Date: 2010-05-26 Impact factor: 7.045
Authors: M E Miettinen; L Reinert; L Kinnunen; V Harjutsalo; P Koskela; H-M Surcel; C Lamberg-Allardt; J Tuomilehto Journal: Diabetologia Date: 2012-01-20 Impact factor: 10.122
Authors: M Shahbazi; M Jeddi-Tehrani; M Zareie; A Salek-Moghaddam; M M Akhondi; M Bahmanpoor; M R Sadeghi; A H Zarnani Journal: Placenta Date: 2011-07-18 Impact factor: 3.481
Authors: Brittni N Frederiksen; Miranda Kroehl; Tasha E Fingerlin; Randall Wong; Andrea K Steck; Marian Rewers; Jill M Norris Journal: J Clin Endocrinol Metab Date: 2013-08-26 Impact factor: 5.958
Authors: Elizabeth Ramos-Lopez; Patrick Brück; Thomas Jansen; Jürgen Herwig; Klaus Badenhoop Journal: Diabetes Metab Res Rev Date: 2007-11 Impact factor: 4.876
Authors: Sarah-Michelle Orton; Andrew P Morris; Blanca M Herrera; Sreeram V Ramagopalan; Matthew R Lincoln; Michael J Chao; Reinhold Vieth; A Dessa Sadovnick; George C Ebers Journal: Am J Clin Nutr Date: 2008-08 Impact factor: 7.045
Authors: German Tapia; Karl Mårild; Sandra R Dahl; Nicolai A Lund-Blix; Marte K Viken; Benedicte A Lie; Pål R Njølstad; Geir Joner; Torild Skrivarhaug; Arieh S Cohen; Ketil Størdal; Lars C Stene Journal: Diabetes Care Date: 2019-01-28 Impact factor: 19.112
Authors: M E Miettinen; L Kinnunen; V Harjutsalo; K Aimonen; H-M Surcel; C Lamberg-Allardt; J Tuomilehto Journal: Eur J Clin Nutr Date: 2016-09-14 Impact factor: 4.016
Authors: Maija E Miettinen; Melissa C Smart; Leena Kinnunen; Valma Harjutsalo; Linnea Reinert-Hartwall; Irene Ylivinkka; Heljä-Marja Surcel; Christel Lamberg-Allardt; Graham A Hitman; Jaakko Tuomilehto Journal: PLoS One Date: 2017-10-04 Impact factor: 3.240